Sarissa is a private limited company. It has secured significant funding from a range of investors including venture capital funds, family offices, private investors, public institutions, founders and management.

Wren Capital have recently made a significant equity investment in Sarissa.
The Wellcome Trust facilitated the formation of Sarissa by providing funding which enabled Prof Dale to create the technology which underpins Sarissa’s biosensors.
The University of Warwick. Sarissa is a Warwick University spin-out. The University acquired a shareholding in the company at the time of its formation and has subsequently made further investments in the company.